IL218042A - Sustained release 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in multiple sclerosis - Google Patents

Sustained release 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in multiple sclerosis

Info

Publication number
IL218042A
IL218042A IL218042A IL21804212A IL218042A IL 218042 A IL218042 A IL 218042A IL 218042 A IL218042 A IL 218042A IL 21804212 A IL21804212 A IL 21804212A IL 218042 A IL218042 A IL 218042A
Authority
IL
Israel
Prior art keywords
neuro
aminopyridine
cognitive
sustained release
multiple sclerosis
Prior art date
Application number
IL218042A
Other languages
Hebrew (he)
Other versions
IL218042A0 (en
Original Assignee
Acorda Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2010/045211 external-priority patent/WO2011019845A1/en
Application filed by Acorda Therapeutics Inc filed Critical Acorda Therapeutics Inc
Publication of IL218042A0 publication Critical patent/IL218042A0/en
Publication of IL218042A publication Critical patent/IL218042A/en

Links

IL218042A 2009-08-11 2012-02-09 Sustained release 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in multiple sclerosis IL218042A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US23306909P 2009-08-11 2009-08-11
US23307709P 2009-08-11 2009-08-11
PCT/US2010/045211 WO2011019845A1 (en) 2009-08-11 2010-08-11 Use of 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in patients with demyelinating and other nervous system conditions
US201161239877P 2011-09-04 2011-09-04

Publications (2)

Publication Number Publication Date
IL218042A0 IL218042A0 (en) 2012-04-30
IL218042A true IL218042A (en) 2017-03-30

Family

ID=46145204

Family Applications (1)

Application Number Title Priority Date Filing Date
IL218042A IL218042A (en) 2009-08-11 2012-02-09 Sustained release 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in multiple sclerosis

Country Status (1)

Country Link
IL (1) IL218042A (en)

Also Published As

Publication number Publication date
IL218042A0 (en) 2012-04-30

Similar Documents

Publication Publication Date Title
IL210804A (en) Benzylidenehydrazides and uses thereof
PT3660073T (en) Low-burst polymers and methods to produce polymers
GB0914644D0 (en) Novel agents and uses thereof
IL201018A0 (en) Novel asparaginases and uses thereof
EP2471799A4 (en) Rare-earth complex and uses thereof
EP2416801A4 (en) Immunogenic composition and uses thereof
ZA201103456B (en) Leukolectins and uses thereof
EP2291377A4 (en) Imidazopyrimidinones and uses thereof
GB0903299D0 (en) Composition and methods
HK1173911A1 (en) Use of 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in patients with multiple sclerosis 4--/-
ZA201202482B (en) Synergistic antiviral composition and use thereof
PL2247601T3 (en) Thiazopyrimidinones and uses thereof
HK1161720A1 (en) Dihydroetorphines and their preparation
ZA201201369B (en) Improvements in and relating to cable-barriers
ZA201000357B (en) 2-Azetidinemethaneamines and 2-pyrrolidinemethaneamines as Taar-Ligands
GB0711469D0 (en) Improvements in or relating to devices
IL218042A (en) Sustained release 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in multiple sclerosis
GB0707069D0 (en) Methods and uses
GB0909792D0 (en) Composition and uses thereof
GB0720760D0 (en) Improvement in or relating to arms
GB0913551D0 (en) Improvements in and relating to copolymers
GB0810150D0 (en) Composition and their uses
GB0810151D0 (en) Composition and their uses
GB0902812D0 (en) Composition and use
GB0808857D0 (en) Methdos and uses

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed